| A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool L Manterola, E Guruceaga, JG Pérez-Larraya, M González-Huarriz, ... Neuro-oncology 16 (4), 520-527, 2014 | 395 | 2014 |
| CircRNAs and cancer: biomarkers and master regulators E Arnaiz, C Sole, L Manterola, L Iparraguirre, D Otaegui, CH Lawrie Seminars in cancer biology 58, 90-99, 2019 | 371 | 2019 |
| Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas MM Alonso, R Diez-Valle, L Manterola, A Rubio, D Liu, N Cortes-Santiago, ... PloS one 6 (11), e26740, 2011 | 289 | 2011 |
| New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies E Larrea, C Sole, L Manterola, I Goicoechea, M Armesto, M Arestin, ... International journal of molecular sciences 17 (5), 627, 2016 | 282 | 2016 |
| Oncogenicity of the developmental transcription factor Sox9 A Matheu, M Collado, C Wise, L Manterola, L Cekaite, AJ Tye, ... Cancer research 72 (5), 1301-1315, 2012 | 260 | 2012 |
| The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae C Guzman-Verri, L Manterola, A Sola-Landa, A Parra, A Cloeckaert, ... Proceedings of the National Academy of Sciences 99 (19), 12375-12380, 2002 | 245 | 2002 |
| mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance L Garros-Regulez, P Aldaz, O Arrizabalaga, V Moncho-Amor, ... Expert opinion on therapeutic targets 20 (4), 393-405, 2016 | 146 | 2016 |
| Regulation of Brucella virulence by the two-component system BvrR/BvrS I López-Goñi, C Guzman-Verri, L Manterola, A Sola-Landa, I Moriyon, ... Veterinary microbiology 90 (1-4), 329-339, 2002 | 146 | 2002 |
| The circulating transcriptome as a source of cancer liquid biopsy biomarkers C Sole, E Arnaiz, L Manterola, D Otaegui, CH Lawrie Seminars in cancer biology 58, 100-108, 2019 | 118 | 2019 |
| The Lipopolysaccharide of Brucella abortus BvrS/BvrR Mutants Contains Lipid A Modifications and Has Higher Affinity for Bactericidal Cationic Peptides L Manterola, I Moriyón, E Moreno, A Sola-Landa, DS Weiss, MHJ Koch, ... Journal of bacteriology 187 (16), 5631-5639, 2005 | 117 | 2005 |
| The circulating transcriptome as a source of non‐invasive cancer biomarkers: concepts and controversies of non‐coding and coding RNA in body fluids M Fernandez‐Mercado, L Manterola, E Larrea, I Goicoechea, M Arestin, ... Journal of cellular and molecular medicine 19 (10), 2307-2323, 2015 | 96 | 2015 |
| Evaluation of a PCR test for the diagnosis of Brucella ovis infection in semen samples from rams L Manterola, A Tejero-Garces, A Ficapal, G Shopayeva, JM Blasco, ... Veterinary microbiology 92 (1-2), 65-72, 2003 | 93 | 2003 |
| BvrR/BvrS-Controlled Outer Membrane Proteins Omp3a and Omp3b Are Not Essential for Brucella abortus Virulence L Manterola, C Guzmán-Verri, E Chaves-Olarte, E Barquero-Calvo, ... Infection and immunity 75 (10), 4867-4874, 2007 | 76 | 2007 |
| Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants MJ Grilló, L Manterola, MJ De Miguel, PM Muñoz, JM Blasco, I Moriyón, ... Vaccine 24 (15), 2910-2916, 2006 | 69 | 2006 |
| Targeted next‐generation sequencing and non‐coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other … CH Lawrie, E Larrea, G Larrinaga, I Goicoechea, M Arestin, ... The Journal of Pathology 232 (1), 32-42, 2014 | 64 | 2014 |
| 1–42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death L Manterola, M Hernando-Rodríguez, A Ruiz, A Apraiz, O Arrizabalaga, ... Translational Psychiatry 3 (1), e219-e219, 2013 | 49 | 2013 |
| The circulating transcriptome as a source of biomarkers for melanoma C Solé, D Tramonti, M Schramm, I Goicoechea, M Armesto, LI Hernandez, ... Cancers 11 (1), 70, 2019 | 45 | 2019 |
| Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)? E Ballabio, M Armesto, CE Breeze, L Manterola, M Arestin, D Tramonti, ... Blood cancer journal 2 (8), e83-e83, 2012 | 43 | 2012 |
| Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients P Errarte, M Beitia, I Perez, L Manterola, CH Lawrie, JD Solano-Iturri, ... PloS one 12 (8), e0181711, 2017 | 38 | 2017 |
| Improved dendritic cell‐based immunization against hepatitis C virus using peptide inhibitors of interleukin 10 N Díaz‐Valdés, L Manterola, V Belsue, JI Riezu‐Boj, E Larrea, ... Hepatology 53 (1), 23-31, 2011 | 38 | 2011 |